10 results
Acute promyelocytic leukemia (blood). Typical morphologic features are bilobed ("butterfly") nuclei with dispersed chromatin, subtle to
Acute promyelocytic ... leukemia (blood ... overt cytoplasmic granules ... #Auer #Rods #Acute ... promyelocytic #leukemia
A 37-year-old woman initially presented with pancytopenia and found to have leukopenia (2.1 × 103/μL) with
abundant cytoplasmic granules ... diagnosed with acute ... (APL) following ... decreased secondary granules ... also described in acute
Leukemias Overview: ALL, CML, AML, APML, CLL

Acute leukemias > 20% blasts in the peripheral blood smear
APML, CLL Acute ... ALL (Acute Lymphoblastic ... (Acute Myeloid ... (Acute Promyelocytic ... distinctive primary granules
Presentation of malignant disease in children 
Pre-school (<5 years old) 
 - Acute lymphoblastic leukaemia
years old) - Acute ... lymphoblastic leukaemia ... School-aged - Acute ... Adolescence - Acute ... Malignant #Childhood #Peds
Here are very large, immature myeloblasts with many nucleoli. A distincitve feature of these blasts is
of crystallized granules ... are typical for acute ... myelogenous leukemia ... (AML) that is most ... Rods #AuerRods #AML
Hyperuricemia - Differential Diagnosis Algorithm
Primary - Over-production
     • Increased turnover of nucleotides
Primary
Differential Diagnosis Algorithm ... Disorders • Acute ... (ALL) • Acute ... Myeloid Leukemia ... Differential #Diagnosis #Algorithm
An algorithm for classifying AML according to the new 2017 WHO Classification. Useful for determining which
An algorithm for ... classifying AML ... Classification #Acute ... #Myeloid #Leukemia ... #Algorithm #WHO2017
Treatment Schema for Standard-Risk Acute Lymphoblastic Leukemia
Induction: 
 • Vincristine, Steroid (dexamethasone), L-Asparaginase, Intrathecal (IT) methotrexate
Consolidation
Standard-Risk Acute ... Lymphoblastic Leukemia ... Cytarabine #ALL ... #Leukemia #Treatment ... oncology #pediatrics #peds
Esophageal Variceal Bleeding - Scoping Summary
GENERAL PRINCIPLES OF MANAGEMENT (VARICEAL-B):
V - Vasoconstrictor therapy: (Octreotide 50mcg bolus
acquired/vasoactive meds ... outcomes Hayat et. al ... presentation AL ... not initiate in acute ... diagnosis #management #algorithm
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... clonal evolution to acute ... myeloid leukemia ... (AML). ... #algorithm #hematology